The recommended dose of Glivec is 400 mg/day for adult patients with unresectable and/or metastatic, malignant GIST. A dose increase from 400 mg to 600 mg or 800 mg for patients …
See full prescribing information for Gleevec. Gleevec is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult patients with Philadelphia chromosome positive chronic …
BI Cares Patient Assistance Portal | Boehringer Ingelheim US
To expedite refill requests, please click here to submit online. Thank you for your patience and understanding during this time. Important updates to the Boehringer Cares Patient Assistance …
The recommended dose of Glivec is 600 mg/day for adult patients in blast crisis. Blast crisis is defined as blasts 30% in blood or bone marrow or extramedullary disease other than …
See full prescribing information for. GLEEVEC. Patients with severe hepatic impairment (2.12): 300 mg/day All doses of Gleevec should be taken with a meal and a large glass of water. …
Novartis Patient Assistance Foundation
Novartis Patient Assistance Foundation (NPAF) provides Novartis medication free of cost to eligible patients without insurance coverage or who cannot afford the cost of the medication. …
Glivec | European Medicines Agency (EMA)
Glivec is used to treat adults with DFSP that cannot be removed with surgery, and in adults who are not eligible for surgery when the cancer has returned after treatment or has spread to …
Strength Pharmaceutical form Route of administration Immediate packaging Pack size EU/1/01/198/002 Glivec 100 mg Capsule, hard Oral use blister (PVC/alu) 24 capsules …
Form/Strength Clinically Relevant Nonmedicinal Ingredients oral Tablets 100 mg and 400 mg Coating : ferric oxide (red), ferric oxide (yellow). For a complete listing see Dosage Forms, …
Glivec 400 mg film-coated tablets - Patient Information
The Patient Information Leaflet (PIL) is the leaflet included in the pack with a medicine.